Long-term Clinical Outcomes of a Phase I Trial of Intravesical Docetaxel in the Management of Non–muscle-invasive Bladder Cancer Refractory to Standard Intravesical Therapy

OBJECTIVES: To report the long-term clinical outcomes and durability of response after treatment with induction intravesical docetaxel. Most novel agents used to treat bacillus Calmette-Guerin refractory high-grade non–muscle-invasive (NMI) bladder cancer are evaluated only after short follow-up per...

Full description

Saved in:
Bibliographic Details
Published in:Urology
Main Authors: Laudano, Melissa A., Barlow, Lamont J., Murphy, Alana M., Petrylak, Daniel P., Desai, Manisha, Benson, Mitchell C., McKiernan, James M.
Format: Artigo
Language:Inglês
Published: 2009
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5508734/
https://ncbi.nlm.nih.gov/pubmed/19913890
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.urology.2009.06.112
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items